Local catheter delivery of novel antisense in de-novo and restenotic coronary arteries: Early and 6 month follow-up from AVAIL study

被引:0
|
作者
Kipshidze, NN [1 ]
Overlie, P [1 ]
Dunlap, T [1 ]
Titus, B [1 ]
Lee, D [1 ]
Lauer, M [1 ]
机构
[1] Lenox Hill Hosp, New York, NY 10021 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:23A / 23A
页数:1
相关论文
共 20 条
  • [1] First human experience with local delivery of novel antisense AVI-4126 with Infiltrator catheter in de novo native and restenotic coronary arteries: 6-month clinical and angiographic follow-up from AVAIL study
    Kipshidze, Nicholas
    Iversen, Patrick
    Overlie, Paul
    Dunlap, Tom
    Titus, Bradley
    Lee, Don
    Moses, Jeffrey
    O'Hanley, Peter
    Lauer, Michael
    Leon, Martin B.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2007, 8 (04) : 230 - 235
  • [2] First human experience with local delivery of novel antisense AVI-4126 with infiltrator catheter in de novo native and restenotic coronary arteries: Six-month clinical and angiographic follow-up from AVAIL study
    Kipshidze, N
    Overlie, P
    Dunlap, T
    Titus, B
    Lee, D
    Lauer, M
    CIRCULATION, 2004, 110 (17) : 757 - 757
  • [3] Local delivery of novel antisense AVI-4126 with infiltrator catheter in de novo native and restenotic coronary arteries: Six-month clinical and angiographic follow-tip from AVAIL study.
    Kipshidze, N
    Overlie, P
    Dunlap, T
    Titus, B
    Lee, D
    Lauer, M
    Leon, MB
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A): : 224E - 224E
  • [4] Stenting without predilatation compared with predilatation stenting in coronary arteries: a randomized study: early and six-month follow-up
    Herz, I
    Solodky, A
    Shor, N
    Teplitzky, I
    Menkes, H
    Rechavia, E
    Hasdai, D
    Brandis, S
    Battler, A
    Assali, A
    EUROPEAN HEART JOURNAL, 2000, 21 : 644 - 644
  • [5] First clinical experience with 17-estradiol-eluting BiodivYsio matrix LO Stent to prevent restenosis in de-novo native coronary arteries: Six-month clinical outcomes and angiographic follow-up from the EASTER trial
    Abizaid, AA
    New, G
    Abizaid, AS
    Costa, M
    Vaz, V
    Kipshidze, N
    Staico, R
    Fares, F
    Mehran, R
    Pinto, I
    Roubin, G
    Iyer, S
    Moses, J
    Leon, M
    Sousa, A
    Sousa, JEM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 56A - 56A
  • [6] One-year follow-up of the SIRIUS study: A randomized study with the sirolimus-eluting Bx VELOCITY in the treatment of patients with de-novo native coronary artery lesions
    Holmes, DR
    Leon, MB
    Moses, JW
    Midwall, J
    Clark, M
    Palacios, I
    Bates, M
    Lopez, J
    Yeung, AC
    Kuntz, RE
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 32A - 33A
  • [7] Long-Term Clinical Follow-Up of Small Coronary De Novo Lesions Treated With a Novel Second-Generation Paclitaxel-Coated Balloon Catheter
    Benezet, Javier
    Serrano, Barbara
    Canadas, Dolores
    Agarrado, Antonio
    Del Rio, Ana
    Oneto, Manuel J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B265 - B265
  • [8] Scandinavian Heart Transplant Everolimus De Novo Study With Early Calcineurin Inhibitors Avoidance (Schedule): Results After 6 Years of Follow-up
    Andreassen, A. K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S18 - S18
  • [9] Polymer-Free Biolimus A9-Coated Stents in the Treatment of De-Novo Coronary Lesions With Short DAPT: 9 Month Angiographic and Clinical Follow-Up of the Prospective, Multicenter BioFreedom USA Clinical Trial
    Waksman, Ron
    Piegari, Guy N.
    Kabour, Ameer
    Cannon, Louis
    Wang, John
    Adams, George
    Solankhi, Naresh
    Smeglin, Anthony
    Kereiakes, Dean J.
    Leiboff, Roy
    Garcia-Garcia, Hector
    Spad, Mia-Ashley
    Torguson, Rebecca
    CIRCULATION, 2016, 134
  • [10] Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 24-month follow-up - BIOSOLVE-II and BIOSOLVE-III
    Haude, Michael
    Ince, Huseyin
    Kische, Stephan
    Abizaid, Alexandre
    Toelg, Ralph
    Lemos, Pedro A.
    Van Mieghem, Nicolas
    Verheye, Stefan
    von Birgelen, Clemens
    Christiansen, Evald
    Barbato, Emanuele
    Neumann, Franz-Josef
    Witzenbichler, Bernhard
    Kaiser, Christoph
    Eeckhout, Eric
    Escaned, Javier
    Garcia-Garcia, Hector
    Waksman, Ron
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B27 - B28